Cleared Traditional

K930043 - ACU-EVAC (FDA 510(k) Clearance)

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K930043 · Acuderm, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1994
Decision
400d
Days
Class 2
Risk

K930043 is an FDA 510(k) clearance for the ACU-EVAC. Classified as Apparatus, Exhaust, Surgical (product code FYD), Class II - Special Controls.

Submitted by Acuderm, Inc. (Ft. Lauderdale, US). The FDA issued a Cleared decision on February 9, 1994 after a review of 400 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 878.5070 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Acuderm, Inc. devices

Submission Details

510(k) Number K930043 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 1993
Decision Date February 09, 1994
Days to Decision 400 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
272d slower than avg
Panel avg: 128d · This submission: 400d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FYD Apparatus, Exhaust, Surgical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.5070
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FYD Apparatus, Exhaust, Surgical

All 74
Devices cleared under the same product code (FYD) and FDA review panel - the closest regulatory comparables to K930043.
PlumeSafe X5 Smoke Management System
K240127 · Conmed Corporation · Aug 2024
8Q10 Surclear Smoke Plume Evacuation System
K233789 · Surnic Corporation · Apr 2024
Medline Smoke Evacuation Shroud
K213068 · Medline Industries, Inc. · Jan 2022
NEBULAE SRS Laparoscopic Surgical Smoke Removal System
K202944 · Northgate Technologies, Inc. · Mar 2021